A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving ...
There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s ...
Researchers from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) have found that tau protein and beta-amyloid – two pathological hallmarks of Alzheimer’s disease – ...
Using a new animal model of Alzheimer’s disease, the study highlights a potential breakthrough in treatment strategies. Unlike current therapies that primarily target a single toxic protein linked to ...
In an exceptionally rare case, a patient with a high genetic risk of developing Alzheimer's appears to have avoided his ...
A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the two key pathological hallmarks of Alzheimer’s—tau protein and beta-amyloid ...
Arlette – stock.adobe.com Tau is a naturally occurring protein that helps stabilize nerve cells. Along with another protein, amyloid beta, tau can build up in the brain and disturb cell function.
Scientists restore a key Alzheimer’s pathway, revealing a potential new treatment by targeting harmful oxysterol buildup.
Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the ...
"While most Alzheimer's research has focused on the buildup of amyloid beta and tau, the polyGR proteins we've found in Alzheimer's brains were unexpected and completely different," said Ranum ...